Residual kidney function and peritoneal dialysisâassociated peritonitis treatment outcomes
Clinical Journal of the American Society of Nephrology | Nov 18, 2017
Abiraterone acetate + prednisolone treatment beyond prostate specific antigen and radiographic progression in metastatic castration-resistant prostate cancer patients
Urologic Oncology: Seminars and Original Investigations | Nov 18, 2017
Randomized phase 2 therapeutic equivalence study of abiraterone acetate fine particle formulation vs. originator abiraterone acetate in patients with metastatic castration-resistant prostate cancer: The STAAR study
Urologic Oncology: Seminars and Original Investigations | Nov 18, 2017